McMahan, Katherine
Wegmann, Frank http://orcid.org/0000-0002-9821-1492
Aid, Malika
Sciacca, Michaela
Liu, Jinyan
Hachmann, Nicole P. http://orcid.org/0000-0002-2100-8461
Miller, Jessica
Jacob-Dolan, Catherine http://orcid.org/0000-0001-6641-0342
Powers, Olivia
Hope, David http://orcid.org/0000-0001-5654-1744
Wu, Cindy http://orcid.org/0000-0001-6924-5346
Pereira, Juliana http://orcid.org/0009-0004-0505-6051
Murdza, Tetyana http://orcid.org/0000-0003-1800-1784
Mazurek, Camille R. http://orcid.org/0000-0002-0899-2548
Hoyt, Amelia http://orcid.org/0000-0003-1307-2508
Boon, Adrianus C. M. http://orcid.org/0000-0002-4700-8224
Davis-Gardner, Meredith http://orcid.org/0000-0002-6133-3613
Suthar, Mehul S.
Martinot, Amanda J. http://orcid.org/0000-0001-6237-6191
Boursiquot, Mona
Cook, Anthony
Pessaint, Laurent
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Tolboom, Jeroen
Serroyen, Jan
Solforosi, Laura http://orcid.org/0000-0003-3786-6468
Costes, Lea M. M.
Zahn, Roland C. http://orcid.org/0000-0003-2822-6231
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Article History
Received: 31 May 2023
Accepted: 7 December 2023
First Online: 14 December 2023
Competing interests
: D.H.B., F.W. and R.C.Z. are listed as co-inventors on provisional SARS-CoV-2 vaccine patents (63/121,482; 63/133,969; 63/135,182). F.W., J.T., J.S., L.S., L.M.M.C. and R.C.Z. are employees and may hold equity in Janssen. The other authors declare no competing interests.